跳至主要内容
临床试验/NCT02741167
NCT02741167Unknown不适用

Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

University of Zurich1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
90
试验地点
1
主要终点
C reactive protein (CRP) mg/l, receiver operating characteristic (ROC)

研究概览

简要总结

The purpose of this study is to assess the dynamics of inflammatory parameters in presence or absence of infectious complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

详细描述

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy is the treatment of choice in patients with primary or secondary peritoneal surface malignancies. However the survival benefit is achieved at the cost of increased morbidity and mortality due to an extensive surgery and intraoperative chemo-therapy. Among complications infectious complications are the most common. The early diagnosis of a potential fatal infection is therefore crucial to ensure a good outcome in patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consecutive adult patients (more than 18 years) subjected to CRS and HIPEC due to peritoneal malignancy.
  • Written informed consent by the participant after information about the research project

排除标准

  • No primary or secondary peritoneal surface malignancy
  • No CRS and HIPEC
  • Pregnancy
  • Younger than 18 years

结局指标

主要结局

C reactive protein (CRP) mg/l, receiver operating characteristic (ROC)

时间窗: 30 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验